Unknown

Dataset Information

0

Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.


ABSTRACT: CD8 T lymphocytes are able to eliminate nascent tumor cells through a process referred to as immune surveillance. However, multiple inhibitory mechanisms within the tumor microenvironment have been described that impede tumor rejection by CD8 T cells, including increased signaling by inhibitory receptors. Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that has been shown repeatedly to promote diverse cellular processes benefiting tumorigenesis. Accordingly, the increased expression of LPA and LPA receptors is a common feature of diverse tumor cell lineages and can result in elevated systemic LPA levels. LPA is recognized by at least 6 distinct G-protein-coupled receptors and several of which are expressed by T cells, although the precise role of LPA signaling in CD8 T cell activation and function has not been defined. Here, we demonstrate that LPA signaling via the LPA5 receptor expressed by CD8 T cells suppresses antigen receptor signaling, cell activation and proliferation in vitro and in vivo. Importantly, in a mouse melanoma model tumor-specific CD8 T cells that are LPA5-deficient are able to control tumor growth significantly better than wild-type tumor-specific CD8 T cells. Together, these data suggest that the production of LPA by tumors serves not only in an autocrine manner to promote tumorigenesis but also as a mechanism to suppress adaptive immunity and highlights a potential novel target for cancer treatment.

SUBMITTER: Oda SK 

PROVIDER: S-EPMC3893823 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Oda Shannon K SK   Strauch Pamela P   Fujiwara Yuko Y   Al-Shami Amin A   Oravecz Tamas T   Tigyi Gabor G   Pelanda Roberta R   Torres Raul M RM  

Cancer immunology research 20131001 4


CD8 T lymphocytes are able to eliminate nascent tumor cells through a process referred to as immune surveillance. However, multiple inhibitory mechanisms within the tumor microenvironment have been described that impede tumor rejection by CD8 T cells, including increased signaling by inhibitory receptors. Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that has been shown repeatedly to promote diverse cellular processes benefiting tumorigenesis. Accordingly, the increased expression  ...[more]

Similar Datasets

| S-EPMC7920854 | biostudies-literature
| S-EPMC8405639 | biostudies-literature
| S-EPMC4128188 | biostudies-literature
| S-EPMC10298074 | biostudies-literature
| S-EPMC4886675 | biostudies-literature
| S-EPMC3584057 | biostudies-literature
| S-EPMC2570507 | biostudies-literature
| S-EPMC2877866 | biostudies-literature
| S-EPMC5048377 | biostudies-literature
| S-EPMC7180799 | biostudies-literature